mRESVIA

Marca svizra · 810533 · Marca cumbinada · En vigur

Inscripziun en il register

Numer da registraziun
810533
Numer da la dumonda
02506/2024
Status
En vigur
Tip
Marca cumbinada
Sco registrada
mRESVIA ((fig.))
Deponida
21-02-2024
Registrada
23-02-2024
Publitgada
23-02-2024
Protegida fin ils
21-02-2034
Lingua da la procedura
tudestg
Classificaziun da Vienna
24.15.02, 24.15.15, 26.03.23, 26.07.18, 26.11.01, 26.11.08, 26.11.13
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Impfstoffe für die Verwendung beim Menschen.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 11-05-2026

    Pegn inscrit

    Pledgee
    Ares Capital Corporation, 245 Park Avenue, 44th Floor, New York 10167, USA

    Published in Swissreg on 11.05.2026

  2. 15-08-2024

    Adressa dal possessur midada

    Owner
    ModernaTx, Inc., 200 Technology Square, 2nd Floor, Cambridge MA 02139, USA → ModernaTx, Inc., 325 Binney Street, Cambridge MA 02142, USA

    Published in Swissreg on 15.08.2024

  3. 29-02-2024

    Curregì

    Published in Swissreg on 29.02.2024

  4. 23-02-2024

    Registrà

    Published in Swissreg on 23.02.2024

Partidas

Possessura

ModernaTx, Inc.

325 Binney Street, Cambridge MA 02142, US

Represententa

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

Creditur da pegn

Ares Capital Corporation

245 Park Avenue 44th Floor, New York 10167, US

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.